Clinical Trials

Colorectal Neoplasms

NCT00107250 2023-08-04

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

50 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00291486 2022-10-10

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

19 enrolled 20 charts

Colorectal Neoplasms

NCT03295084 2020-10-05

Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors

39 enrolled

Colorectal Neoplasms

NCT01705002 2018-07-10

Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.

88 enrolled

Neoplasms, Colorectal Neoplasms

NCT01843725 2018-01-31

MOMENTUM1

37 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00536809 2017-12-18

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

12 enrolled 6 charts

Colorectal Neoplasms

NCT02210364 2016-12-14

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

81 enrolled

Breast Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01493336 2016-11-02

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

37 enrolled

Breast Neoplasms, Colorectal Neoplasms

NCT02720926 2016-03-28

Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer

Phase 1 Terminated

3 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT00353262 2016-03-04

A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

36 enrolled 18 charts

Colorectal Neoplasms

NCT00920868 2016-02-03

XAD

22 enrolled

Colorectal Neoplasms

NCT00019773 2015-04-29

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Appendiceal Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01157052 2014-10-01

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Phase 1 Unknown

15 enrolled

Colorectal Neoplasms

NCT00183833 2014-05-22

Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors

40 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT01306630 2014-01-27

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

24 enrolled

Colorectal Neoplasms

NCT01846650 2013-10-01

A Bioequivalence Study of Capecitabine Tablets

36 enrolled

Breast Neoplasms, Colorectal Neoplasms

NCT00532909 2012-07-16

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

13 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00296062 2012-01-16

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Phase 1 Terminated

12 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00084591 2010-02-12

Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer